|
|
||||||||
and Its Ligand on BloodRetinal Barrier in a Streptozotocin-Induced Diabetic Model
1From the Department of Ophthalmology, University of Tokyo School of Medicine, Tokyo, Japan; the 2Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Yokohama, Japan; and the 3Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
PURPOSE. To clarify whether endogenous peroxisome proliferator-activated receptor
(PPAR
) and its ligand, rosiglitazone, affect retinal leukostasis and the associated vascular leakage using an experimental diabetic model.
METHODS. Diabetes was induced in heterozygous PPAR
+/ mice and Brown Norway rats with an intraperitoneal streptozotocin (STZ) injection. Retinal leukostasis and leakage, quantified by concanavalin A (Con A) lectin perfusion labeling combined with a fluorophotometric dextran leakage assay, were investigated at 120 days in diabetic PPAR
+/ and wild-type mice and at 21 days in diabetic rats receiving rosiglitazone or the vehicle. The retinal protein expression levels of vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF)-
, and the intercellular adhesion molecule (ICAM)-1 were investigated by means of the ELISA assay.
RESULTS. In the diabetic PPAR
+/ mice, retinal leukostasis and leakage were greater than in the diabetic wild-type mice. In addition retinal leukostasis and leakage were suppressed by treatment with rosiglitazone in experimental diabetic rats. ELISA analysis revealed that the upregulated ICAM-1 expression in the diabetic rat retina was reduced by rosiglitazone treatment.
CONCLUSIONS. An endogenous pathway involving PPAR
provides protection against retinal leukostasis and retinal leakage in diabetes and treatment with PPAR
specific ligands inhibits retinal leukostasis and retinal leakage in diabetic rats.
This article has been cited by other articles:
![]() |
A. Higuchi, K. Ohashi, R. Shibata, S. Sono-Romanelli, K. Walsh, and N. Ouchi Thiazolidinediones Reduce Pathological Neovascularization in Ischemic Retina Via an Adiponectin-Dependent Mechanism Arterioscler Thromb Vasc Biol, January 1, 2010; 30(1): 46 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Kirwin, S. T. Kanaly, N. A. Linke, and J. L. Edelman Strain-Dependent Increases in Retinal Inflammatory Proteins and Photoreceptor FGF-2 Expression in Streptozotocin-Induced Diabetic Rats Invest. Ophthalmol. Vis. Sci., November 1, 2009; 50(11): 5396 - 5404. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huang, S. Y. Eum, I. E Andras, B. Hennig, and M. Toborek PPAR{alpha} and PPAR{gamma} attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities FASEB J, May 1, 2009; 23(5): 1596 - 1606. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zheng, H. Chen, G. Ke, Y. Fan, H. Zou, X. Sun, Q. Gu, X. Xu, and P. C.P. Ho Protective Effect of Perindopril on Diabetic Retinopathy Is Associated With Decreased Vascular Endothelial Growth Factor-to-Pigment Epithelium-Derived Factor Ratio: Involvement of a Mitochondria-Reactive Oxygen Species Pathway Diabetes, April 1, 2009; 58(4): 954 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tawfik, T. Sanders, K. Kahook, S. Akeel, A. Elmarakby, and M. Al-Shabrawey Suppression of Retinal Peroxisome Proliferator-Activated Receptor {gamma} in Experimental Diabetes and Oxygen-Induced Retinopathy: Role of NADPH Oxidase Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 878 - 884. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |